The Robert Lucas journal of the war of 1812 during the campaign under General William Hall,1906.

Journal of Iowa Territorial Governor Robert Lucas on the Hall campaign which was to march to Detroit and commence a conquest of Canada. This journal is edited by John c. Parish.

[Illustrations de Exercitatio anatomica de motre cordis et sanguinis in animalibus...] / [Non identifié] ; William Harvey, aut. du texte

Comprend : [ Frontispice avec figures. Ange, colonne avec devise et écusson. XVIIè siècle.] [ Cote : BNF C 149052. ] ; [ Planche entre pp.8-9. Dissection et anatomie. Présentation des veines de l'avant-bras. XVIIè siècle.] [ Cote : BNF C 28692. ]

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease.

The mechanisms underlying preferential atrophy of the striatum in Huntington's disease (HD) are unknown. One hypothesis is that a set of gene products preferentially expressed in the striatum could determine the particular vulnerability of this brain region to mutant huntingtin (mHtt). Here, we studied the striatal protein µ-crystallin (Crym). Crym is the NADPH-dependent p38 cytosolic T3-binding protein (p38CTBP), a key regulator of thyroid hormone (TH) T3 (3,5,3'-triiodo-l-thyronine) transportation. It has been also recently identified as the enzyme that reduces the sulfur-containing cyclic ketimines, which are potential neurotransmitters. Here, we confirm the preferential expression of the Crym protein in the rodent and macaque striatum. Crym expression was found to be higher in the macaque caudate than in the putamen. Expression of Crym was reduced in the BACHD and Knock-in 140CAG mouse models of HD before onset of striatal atrophy. We show that overexpression of Crym in striatal medium-size spiny neurons using a lentiviral-based strategy in mice is neuroprotective against the neurotoxicity of an N-terminal fragment of mHtt in vivo. Thus, reduction of Crym expression in HD could render striatal neurons more susceptible to mHtt suggesting that Crym may be a key determinant of the vulnerability of the striatum. In addition our work points to Crym as a potential molecular link between striatal degeneration and the THs deregulation reported in HD patients.

Catalogue des estampes anciennes des écoles anglaise et française du XVIIIe siècle imprimées en nopir et en couleurs, caricatures, costumes..., portraits et pièces historiques..., dont la vente, après décès de M. Victorien Sardou, aura lieu à Paris, hôtel des commissaires-priseurs... les 5, 6, 7 et 8 mai 1909... / [expert] A. Danlos

[Vente. Estampes. 1909-05-05 - 1909-05-08. Paris]

Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

Highly quantitative biomarkers of neurodegenerative disease remain an important need in the urgent quest for disease-modifying therapies. For Huntington's disease (HD), a genetic test is available (trait marker), but necessary state markers are still in development. In this report, we describe a large battery of transcriptomic tests explored as state biomarker candidates. In an attempt to exploit the known neuroinflammatory and transcriptional perturbations of disease, we measured relevant mRNAs in peripheral blood cells. The performance of these potential markers was weak overall, with only one mRNA, immediate early response 3 (IER3), showing a modest but significant increase of 32% in HD samples compared with controls. No statistically significant differences were found for any other mRNAs tested, including a panel of 12 RNA biomarkers identified in a previous report [Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, et al. (2005) Proc Natl Acad Sci USA 102:11023-11028]. The present results may nonetheless inform the future design and testing of HD biomarker strategies.